Delphia Therapeutics, Inc. (Delphia), a biopharmaceutical company pioneering an innovative new area of cancer biology – activation lethality – which targets cancer's surprising vulnerability to ...
Delphia, a membership-based investment collective where people pool their data to gain access to exclusive investment strategies, has launched the Delphia 500, an active investment strategy that uses ...